Step Pharma Funding: $146M Raised, Series C (2023)

Step Pharma funding overview

Step Pharma is based in Paris, France. Step Pharma has raised $146M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in October 2023. The round record for Step Pharma runs through 2023; nothing later has been disclosed. Investors on record include V-Bio Ventures, Pontifax Venture Capital, Bpifrance, Kurma Partners, Hadean Ventures, Sunstone Life Science Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.

Step Pharma at a glance

Total raised: $146M
Latest round: Series C
Latest round date: October 2023
Headquarters: Paris, France
Notable investors: V-Bio Ventures, Pontifax Venture Capital, Bpifrance, Kurma Partners, Hadean Ventures, Sunstone Life Science Ventures, Inserm Transfert Initiative

Frequently asked about Step Pharma funding

How much has Step Pharma raised?: Step Pharma has raised $146M in total disclosed funding across the rounds on record.
Who has invested in Step Pharma?: V-Bio Ventures, Pontifax Venture Capital, Bpifrance, Kurma Partners, Hadean Ventures, Sunstone Life Science Ventures are named among the investors backing Step Pharma.
What was the latest Step Pharma funding round?: The most recent disclosed round is a Series C, announced in October 2023.
Where is Step Pharma based?: Step Pharma is based in Paris, France.
When did Step Pharma last raise?: The last disclosed Step Pharma round closed in October 2023 at Series C.

Step Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Paris below to benchmark round size and investor mix.

Step Pharma Funding: $146M Raised, Series C (2023)

Step Pharma funding overview

Step Pharma at a glance

Frequently asked about Step Pharma funding

Companies related to Step Pharma (31)

Browse related funding lists (9)